Follow
Vana Sypsa
Title
Cited by
Cited by
Year
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ...
The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017
21132017
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ...
The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018
15572018
Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems
GL Daikos, S Tsaousi, LS Tzouvelekis, I Anyfantis, M Psichogiou, ...
Antimicrobial agents and chemotherapy 58 (4), 2322-2328, 2014
7172014
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ...
Journal of viral hepatitis 21, 34-59, 2014
674*2014
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
G Papatheodoridis, G Dalekos, V Sypsa, C Yurdaydin, M Buti, J Goulis, ...
Journal of hepatology 64 (4), 800-806, 2016
4622016
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ...
The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022
3632022
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study
EUHCV COLLABORATORS
Lancet Gastroenterol Hepatol 2, 161-76, 0
322*
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study
EUHCV COLLABORATORS
Lancet Gastroenterol Hepatol 2, 325-36, 2017
3152017
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B
GV Papatheodoridis, R Idilman, GN Dalekos, M Buti, H Chi, ...
Hepatology 66 (5), 1444-1453, 2017
3032017
The effectiveness of a 9-month regimen of isoniazid alone versus 3-and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children …
NP Spyridis, PG Spyridis, A Gelesme, V Sypsa, M Valianatou, F Metsou, ...
Clinical Infectious Diseases 45 (6), 715-722, 2007
2972007
Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis
GK Nikolopoulo, D Paraskevis, E Hatzitheodorou, Z Moschidis, V Sypsa, ...
Clinical Infectious Diseases 48 (12), 1763-1771, 2009
2842009
Associations between fine and coarse particles and mortality in Mediterranean cities: results from the MED-PARTICLES project
E Samoli
Environ Health Perspect, 2013
2522013
Short-term associations between fine and coarse particulate matter and hospitalizations in Southern Europe: results from the MED-PARTICLES project
M Stafoggia
Environ Health Perspect 121, 1026-33, 2013
2522013
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
R Fan, G Papatheodoridis, J Sun, H Innes, H Toyoda, Q Xie, S Mo, ...
Journal of hepatology 73 (6), 1368-1378, 2020
2242020
Desert Dust Outbreaks in Southern Europe: Contribution to Daily PM(1)(0) Concentrations and Short-Term Associations with Mortality and Hospital Admissions
M Stafoggia
Environ Health Perspect, 2016
1962016
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
GV Papatheodoridis, GN Dalekos, C Yurdaydin, M Buti, J Goulis, ...
Journal of hepatology 62 (2), 363-370, 2015
1812015
A survey of bloodborne viruses and associated risk behaviours in Greek prisons
M Malliori, V Sypsa, M Psichogiou, G Touloumi, A Skoutelis, ...
Addiction 93 (2), 243-251, 1998
1641998
Public perceptions in relation to intention to receive pandemic influenza vaccination in a random population sample: evidence from a cross-sectional telephone survey
V Sypsa, T Livanios, M Psichogiou, M Malliori, S Tsiodras, ...
Eurosurveillance 14 (49), 2009
1462009
Historical epidemiology of hepatitis C virus (HCV) in select countries–volume 2
V Saraswat, S Norris, RJ De Knegt, JF Sanchez Avila, M Sonderup, ...
Journal of viral hepatitis 22, 6-25, 2015
1432015
Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
C Arum, H Fraser, AA Artenie, S Bivegete, A Trickey, M Alary, ...
The Lancet public health 6 (5), e309-e323, 2021
1412021
The system can't perform the operation now. Try again later.
Articles 1–20